Hannover Rueck (DE:HNR1)
XETRA:HNR1
Want to see DE:HNR1 full AI Analyst Report?
Top Page
Hannover Rueck
(XETRA:HNR1)
Select Model
Select Model
Rating:71Outperform
Price Target:
€261.00
▼(-5.30% Downside)
Action:Reiterated
Date:05/15/26
The score is primarily supported by solid financial strength (healthy ROE, strong net income, and controlled leverage), while being meaningfully offset by weak recent free-cash-flow conversion. Technically, the stock shows bearish trend signals despite oversold readings. Valuation is a clear positive with a very low P/E and strong dividend yield.
Positive Factors
Strong profitability & ROE
Sustained double-digit ROE and an ~11% net margin indicate recurring underwriting plus investment profitability. That level of profitability supports internal capital build, reserve strengthening and dividend capacity, enhancing long-term financial resilience across cycles.
Negative Factors
Free cash flow deterioration
The drop of FCF to zero reduces discretionary capacity for buybacks, extra dividends or balance sheet deleveraging. Over several quarters this weakens financial flexibility and raises reliance on investment returns or capital injections to fund strategic initiatives or absorb large losses.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong profitability & ROE
Sustained double-digit ROE and an ~11% net margin indicate recurring underwriting plus investment profitability. That level of profitability supports internal capital build, reserve strengthening and dividend capacity, enhancing long-term financial resilience across cycles.
Read all positive factors
Hannover Rueck (HNR1) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€29.45B
Dividend Yield3.37%
Average Volume (3M)112.70K
Price to Earnings (P/E)1.1
Beta (1Y)0.67
Revenue Growth-2.57%
EPS Growth27.56%
CountryDE
Employees3,895
SectorGeneral
Sector StrengthN/A
IndustryInsurance - Reinsurance
Share Statistics
EPS (TTM)76.83
Shares Outstanding120,597,140
10 Day Avg. Volume124,930
30 Day Avg. Volume112,700
Financial Highlights & Ratios
PEG Ratio0.91
Price to Book (P/B)2.48
Price to Sales (P/S)1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€291.44Price Target Upside5.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)22.98
Revenue Forecast (FY)€27.35B
Hannover Rueck Business Overview & Revenue Model
Company Description
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The company offers property, casualty, facultative...
How the Company Makes Money
Hannover Rueck makes money primarily through (1) underwriting income from reinsurance and (2) investment income on the assets it holds to pay future claims. Underwriting income is generated by collecting reinsurance premiums from insurance compani...
Hannover Rueck Financial Statement Overview
Summary
Income Statement
76
Positive
Balance Sheet
82
Very Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.77B | 26.80B | 2.66B | 21.98B | 1.39B | 26.28B |
| Gross Profit | 82.77B | 26.80B | 2.53B | 21.35B | 1.31B | 26.28B |
| EBITDA | 1.80B | 0.00 | 3.37B | 2.01B | 1.44B | 1.71B |
| Net Income | 9.21B | 2.64B | 2.33B | 1.82B | 780.80M | 1.23B |
Balance Sheet | ||||||
| Total Assets | 73.44B | 71.33B | 72.13B | 65.67B | 62.96B | 82.90B |
| Cash, Cash Equivalents and Short-Term Investments | 1.14B | 1.05B | 57.39B | 1.05B | 48.81B | 49.19B |
| Total Debt | 4.14B | 4.14B | 4.67B | 4.88B | 5.51B | 4.37B |
| Total Liabilities | 58.56B | 57.40B | 59.44B | 54.65B | 53.00B | 70.15B |
| Stockholders Equity | 13.87B | 12.93B | 11.79B | 10.13B | 9.06B | 11.89B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | 5.68B | 5.79B | 4.95B | 4.94B |
| Operating Cash Flow | 5.88B | 5.69B | 5.68B | 5.79B | 4.95B | 4.94B |
| Investing Cash Flow | -4.09B | -4.05B | -4.41B | -4.51B | -5.08B | -5.26B |
| Financing Cash Flow | -1.72B | -1.72B | -1.10B | -1.50B | 44.30M | 277.51M |
Hannover Rueck Technical Analysis
Negative
275.60
Price Trends
250.49
Negative
242.65
Negative
242.44
Negative
Market Momentum
-2.31
Negative
44.75
Neutral
56.26
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:HNR1, the sentiment is Negative. The current price of 275.6 is above the 20-day moving average (MA) of 242.96, above the 50-day MA of 250.49, and above the 200-day MA of 242.44, indicating a bearish trend. The MACD of -2.31 indicates Negative momentum. The RSI at 44.75 is Neutral, neither overbought nor oversold. The STOCH value of 56.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:HNR1.
Hannover Rueck Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €28.03B | 8.81 | 27.86% | 2.37% | 3.40% | 31.91% | |
71 Outperform | €29.45B | 1.14 | 73.88% | 3.37% | -2.57% | 27.56% | |
71 Outperform | €148.07B | 9.25 | 19.58% | 3.94% | ― | ― | |
67 Neutral | €60.18B | 10.10 | 20.64% | 3.56% | -1.59% | 49.39% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
DE:HNR1
Hannover Rueck
242.00
-22.08
-8.36%
DE:ALV
Allianz
388.90
56.02
16.83%
DE:MUV2
Munich Reinsurance
473.10
-65.96
-12.24%
DE:TLX
Talanx AG
107.80
-2.58
-2.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.